Latest Breaking News On - Ionis pharmaceuticals daily - Page 8 : vimarsana.com

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) EVP Eric Swayze Sells 10,773 Shares

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) EVP Eric Swayze sold 10,773 shares of the stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $52.00, for a total transaction of $560,196.00. Following the transaction, the executive vice president now owns 32,516 shares in the company, valued […]

United statesNew jerseyEric swayzeStifel nicolausNeedham companyQuarter for ionis pharmaceuticalsIonis pharmaceuticalsNews ratings for ionis pharmaceuticals dailyGoldman sachs groupTruist financial corpIonis pharmaceuticals incHedge funds weigh in on ionis pharmaceuticalsLtd zurichJpmorgan chase coIonis pharmaceuticals company profileBank julius baer co

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) EVP Patrick R O neil Sells 6,450 Shares

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) EVP Patrick R O neil Sells 6,450 Shares
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandUnited statesPatrickr oneilPiper sandlerIonis pharmaceuticals incIonis pharmaceuticalsNews ratings for ionis pharmaceuticals dailyRoyal bankQuarter for ionis pharmaceuticalsWellington management groupIonis pharmaceuticals stock downGoldman sachs groupNorges bankGet free reportPharmaceuticals stock down

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Given Consensus Recommendation of Moderate Buy by Brokerages

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Given Consensus Recommendation of Moderate Buy by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerStifel nicolausVictory capital management incSecurities exchange commissionIonis pharmaceuticalsNews ratings for ionis pharmaceuticals dailyInsider activity at ionis pharmaceuticalsHedge funds weigh in on ionis pharmaceuticalsGoldman sachs groupXponance incIonis pharmaceuticals trading downBleakley financial groupAnalyst recommendations for ionis pharmaceuticalsIonis pharmaceuticals incGet free report

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Receives $49 07 Consensus Target Price from Analysts

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Receives $49 07 Consensus Target Price from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairPatrickr oneilPiper sandlerPeoples bankInsider transactions at ionis pharmaceuticalsHedge funds weigh in on ionis pharmaceuticalsAlmanack investment partnersMorgan stanleyIonis pharmaceuticals incIonis pharmaceuticals company profileNews ratings for ionis pharmaceuticals dailyAnalyst recommendations for ionis pharmaceuticalsIonis pharmaceuticals trading downGoldman sachs groupIonis pharmaceuticals

Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Receives $49 07 Consensus Target Price from Brokerages

Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) have received a consensus rating of “Moderate Buy” from the fourteen research firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell rating, four have given a hold rating, seven have given a buy rating and one […]

United statesC frank bennettStifel nicolausPatrickr oneilPiper sandlerHandelsinvest investeringsforvaltningMorgan stanleyInsider activity at ionis pharmaceuticalsIonis pharmaceuticals incChina universal asset management coLegato capital managementHedge funds weigh in on ionis pharmaceuticalsIonis pharmaceuticals stock downNews ratings for ionis pharmaceuticals dailyThird bancorpFifth third bancorp